The Centers for Medicare & Medicaid Services Aug. 3 issued a proposed rule that would update physician fee schedule payments for calendar year 2021. The rule also included several proposals to implement year five of the quality payment program created by the Medicare Access and CHIP Reauthorization Act of 2015.

Among other proposals, CMS would:

  • Reduce the PFS conversion factor by 10.61% for CY 2021;
  • Add services to the Medicare telehealth list of services and make other changes to retain certain COVID-19 telehealth flexibilities;
  • Increase payment rates for office/outpatient evaluation and management visits;
  • Implement changes to enable health care professionals to practice at the top of their licenses;
  • Delay the next Clinical Laboratory Fee Schedule data reporting period by an additional year so that hospital outreach laboratories would not need to report private payer data until Jan. 1, 2022 through March 31, 2022;
  • Eliminate the phase-in of CLFS payment cuts in 2021; and
  • Implement provisions of the Substance Use-disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act, including Medicare coverage for opioid treatment programs, screening for substance use disorder in Medicare physicals, and electronic prescribing of controlled substances.

Comments on the proposed rule are due by Oct. 5.

Related News Articles

Headline
The Centers for Medicare & Medicaid Services has issued the 2025-2026 Medicaid Managed Care Rate Development Guide for states to use when setting managed…
Headline
The AHA, joined by several other national groups representing 340B hospitals, Aug. 8 urged the Health Resources and Services Administration to extend the…
Headline
The AHA today filed an amicus brief in the U.S. Court of Appeals for the D.C. Circuit, defending the Department of Health and Human Services’ decision to…
Headline
The Department of Health and Human Services today issued a notice announcing a 340B Rebate Model Pilot Program as a voluntary mechanism for qualifying drug…
Headline
Rep. Doris Matsui, D-Calif., and Sen. Peter Welch, D-Vt., today introduced the 340B Patients Act, AHA-supported legislation that would codify 340B providers'…
Headline
The AHA July 16 filed an amicus brief in the U.S. District Court for the District of Colorado in defense of the state’s 340B contract pharmacy law prohibiting…